Portal:CPTAC/Hallmark/Therapeutics

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(added pw titles)
Line 1: Line 1:
-
*[[Pathway:WP3672]]
+
*[[Pathway:WP3672]] LncRNA-mediated mechanisms of therapeutic resistance
-
*[[Pathway:WP3640]]
+
*[[Pathway:WP3640]] Imatinib and Chronic Myeloid Leukemia
-
*[[Pathway:WP3614]]
+
*[[Pathway:WP3614]] Photodynamic therapy-induced HIF-1 survival signaling
-
*[[Pathway:WP3617]]
+
*[[Pathway:WP3617]] Photodynamic therapy-induced NF-kB survival signaling
-
*[[Pathway:WP3879]]
+
*[[Pathway:WP3879]] 4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression
-
*[[Pathway:WP1601]]
+
*[[Pathway:WP1601]] Fluoropyrimidine Activity

Revision as of 03:13, 6 October 2017

Personal tools